SynthesisFrontiers in pharmacology2026
Characteristics of pediatric drug-related investigator-initiated trials in Chinese children's hospitals: a comparative analysis based on ChiCTR and ClinicalTrials.gov registration data.
Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize the registration characteristics of investigator-initiated pediatric drug trials (IITs) conducted in Chinese children's hospitals and compare registration patterns between ChiCTR and ClinicalTrials.gov, thereby providing evidence to support future pediatric drug clinical research. Methods: Pediatric interventional trial registrations were retrieved from ChiCTR and ClinicalTrials.gov from database inception to December 31, 2024. Eligible studies met the following inclusion criteria: participants aged <18 years, interventions involving pediatric medicines, research sites including children's hospitals, and studies meeting the criteria for IITs. Results: A total of 749 registrations of pediatric drug-related IITs were included, including 527 from ChiCTR and 222 from ClinicalTrials.gov. The number of pediatric drug-related IIT registrations conducted in Chinese children's hospitals showed an overall increasing trend. The included trials primarily involved infants, children, and adolescents, with exploratory trials/preliminary studies and post-marketing drug studies representing the predominant research stages. Geographic distribution patterns differed between the two databases, and international multicenter trials remained limited. Chemical drugs and biological products were the predominant drug categories, whereas studies involving traditional Chinese medicines/natural products were relatively insufficient. Conclusion: Although registrations of pediatric drug-related IITs conducted in Chinese children's hospitals have increased in recent years, imbalances remain in the distribution of study populations, drug categories, disease areas, and research institutions. Further efforts are needed to strengthen multicenter collaboration and establish supportive systems for pediatric clinical research, thereby facilitating the accumulation of evidence for pediatric medication evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.